Daiichi Sankyo,
Eisai, Epicept, Exelixis, Genentech, GlaxoSmithKline, Human Genome
Sciences, ImClone, Infinity, Lilly, Medimmune, Merck, Merck Serono,
Nerviano, Novartis, Oncothyreon, OSI Pharmaceuticals, Piramed, Pfizer,
Prolexys, Regeneron, Roche, Sanofi-Aventis, Semafore, Vertex.
The full report can be purchased by contacting MedPredict.
About MedPredict
MedPredict (http://www.medpredict.com) maintains a proprietary database
of over 1,000 global physician thought leaders, including 40+ specialties
in 30+ therapeutic categories. Based on primary interviews with these
thought leaders, MedPredict publishes periodic reports in each category to
keep clients up-to-date on emerging trends and competitive activity. The
reports include thought leader reactions to recent publications and medical
conferences, as well as clinical, regulatory and marketing activity.
'/>"/>SOURCE MedPredict Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 Related medicine technology :1.
Avastin(R) Shows Unprecedented Benefits in Colorectal Cancer Patients, Irrespective of K-Ras Gene Mutation2.
CuraGen Announces Initiation of Phase II Trial of CR011-vcMMAE in Patients with Advanced Breast Cancer3.
Genmab Initiates Study of Zalutumumab With Radiotherapy in Head and Neck Cancer4.
First Breast Cancer Patient Receives Treatment in National Electronic Brachytherapy Registry Launched by Three Physician Societies5.
CB1400, Patented by Canopus BioPharma, Enters Phase II Clinical Trials for the Prevention of Mucositis in Patients With Cancer of the Head and Neck6.
GlaxoSmithKline Collaborates with National Cancer Institute to Make Large Body of Cancer Cell Genomic Data Available to All Cancer Researchers7.
New Australian Technology: Detecting Breast Cancer With Hair8.
GeneGo is Awarded NCI Grant for Development of Systems Biology Platform for Integrative Data Analysis in Cancer9.
Fox Chase Cancer Center and VisEn Medical Announce Program to Advance First Clinical Trials of Novel Fluorescence Molecular Imaging Technologies10.
Bionovo Elucidates Mechanism of Breast Cancer Control by Estrogen Receptor Beta11.
Bionovo Discovers New Estrogen Regulatory Elements for Breast Cancer and Osteoporosis Drugs